DOCSLIB.ORG

Β-Hairpin Antimicrobial Peptides

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Β-Hairpin Antimicrobial Peptides β-hairpin antimicrobial peptides: structure, function and mode of action Ingrid Alexia Edwards MSc Chemistry and chemical engineering A thesis submitted for the degree of Doctor of Philosophy at The University of Queensland in 2018 Institute for Molecular Bioscience Abstract Abstract A ‘state of emergency’ was declared by the World Health Organization three years ago to combat the increasing rate of resistance arising in bacteria to all currently available antibiotics on the market. Antimicrobial resistance is now a worldwide concern, and renewed efforts are needed in the search for new replacement drugs for obsolete antibiotics. Antimicrobial peptides (AMPs) have been discovered and studied over decades; importantly very limited bacterial resistance has been reported to date. The work here aims to better characterize and understand the structure-function relationships of select β-hairpin AMPs, leading to the design of novel, optimized and potentially therapeutically valuable peptides. Chapter 1 reviews the field of β-hairpin AMPs and provides a background for the specific AMPs studied in this thesis. Chapter 2 consists of an original data set that strengthens the current knowledge of β-hairpin AMPs by comparing their activity profile under similar conditions. This work analysed the contribution of amphipathicity and hydrophobicity to antimicrobial activity and cytotoxicity of β- hairpin peptides, concluding that a very fine balance between charge, hydrophobicity, amphipathicity, secondary and tertiary structure and mode of action is needed for a peptide to be therapeutically valuable. From this study, two distinct but linked areas of further investigation were identified (i) a structure activity and function relationship study and (ii) a determination of the mode of action of select β-hairpin AMPs. Chapter 2 identified that tachyplesin-1, a 17 amino acids β-hairpin AMP originating from the hemocyte debris of a horseshoe crab, Tachypleus tridentatus, was an ideal β-hairpin AMP candidate to study structure-activity and -toxicity relationships, as it possessed an 8-fold higher therapeutic index than other β-hairpin AMPs studied. Thus, chapter 3 contains an evaluation of the role of each amino acid of tachyplesin-1 through an alanine scan. New analog peptides were designed as a systematic approach to develop more therapeutically valuable peptides as replacements for antibiotics that have become ineffective. Measurements of activity and toxicity, combined with preliminary ADME data, led to the identification of two tachyplesin-1 analogs with great potential for future drug development. Chapters 4 and 5 consist of studies of the mode of action of arenicin-3, a 21 amino acid β-hairpin AMP originating from the coelomocytes of marine polychaeta lugworm, Arenicola marina, and its synthetic analog AA139. AA139 is a lead drug candidate of Adenium Biotech Ltd. currently in preclinical development for MDR urinary tract infection and MDR Gram-negative pneumonial diseases. Their 3D NMR solution structures revealed right handed twisted β-hairpin structures of 21 I Abstract amino acids rigidified by two disulfide bridges (Cys3-Cys20 and Cys7-Cys16). The mode of action of arenicin peptides and their selectivity toward bacteria cells, and more specifically their interaction toward different lipid membrane systems, were examined. Chapter 4 focused on label free mode of action investigations, leading to a proposed model of arenicin mode of action involving three steps: (1) binding to the outer membrane through electrostatic interactions, (2) insertion into the hydrophobic core of the outer membrane creating partial permeabilization due to the ability of the peptide to modify its secondary structure allowing it to enter into the lipid bilayer without pore formation, (3) accessing and partially permeabilizing the cytoplasmic membrane. To provide further evidence of the arenicin peptides mode of action, chapter 5 contains a comprehensive structural investigation employing NMR experiments with 15N labelled AA139 in the presence of lipid bilayer model membranes, nanodiscs or vesicles, using solution and solid-state NMR, respectively. This work suggested that the C- and N-terminal of AA139 are the first point of interaction with lipid bilayer membranes. Following that first interaction, AA139 possibly undergoes a loss of its well-defined 3D solution structure, becoming dynamic and without a distinct fold whilst embedded in the membrane and causing the permeabilization of both outer and inner membranes. This study allowed us to gain a deeper understanding of AA139 mode of action, and of the differences between the successful lead drug candidate, AA139 and its therapeutically less valuable progenitor, arenicin-3. This study provides an example of potential approaches to employ when designing other improvements to antimicrobial peptides. More importantly, this study allowed us to confirm the great potential of nanodiscs, not only to study membrane proteins, but also to evaluate the mode of action of membrane- active peptides. II Declaration by author This thesis is composed of my original work, and contains no material previously published or written by another person except where due reference has been made in the text. I have clearly stated the contribution by others to jointly-authored works that I have included in my thesis. I have clearly stated the contribution of others to my thesis as a whole, including statistical assistance, survey design, data analysis, significant technical procedures, professional editorial advice, financial support and any other original research work used or reported in my thesis. The content of my thesis is the result of work I have carried out since the commencement of my higher degree by research candidature and does not include a substantial part of work that has been submitted to qualify for the award of any other degree or diploma in any university or other tertiary institution. I have clearly stated which parts of my thesis, if any, have been submitted to qualify for another award. I acknowledge that an electronic copy of my thesis must be lodged with the University Library and, subject to the policy and procedures of The University of Queensland, the thesis be made available for research and study in accordance with the Copyright Act 1968 unless a period of embargo has been approved by the Dean of the Graduate School. I acknowledge that copyright of all material contained in my thesis resides with the copyright holder(s) of that material. Where appropriate I have obtained copyright permission from the copyright holder to reproduce material in this thesis and have sought permission from co-authors for any jointly authored works included in the thesis. III Publications included in this thesis Edwards, IA, Elliott, AG, Kavanagh, AM, Zuegg, J, Blaskovich, MAT, Cooper, MA, (2016), Contribution of amphipathicity and hydrophobicity to the antimicrobial activity and cytotoxicity of β-hairpin peptides, ACS Inf. dis. DOI: 10.1021/acsinfecdis.6b00045 Edwards, IA, Elliott, AG, Kavanagh, AM, Blaskovich, MAT, Cooper, MA, (2017), Structure-activity and -toxicity relationships of the antimicrobial peptide tachyplesin-1, ACS Inf. dis. DOI:10.1021/acsinfecdis.7b00123 Submitted manuscripts included in this thesis No manuscripts submitted for publication. Other publications during candidature Conference abstracts Edwards, IA, Mobli, M, Zuegg, J, Cooper, MA. Arenicin-3 peptides: β-hairpin AMPs structures and mode of action. 11th Australian peptides conferences, Kingscliff, Australia, October 2015 Edwards, IA, Elliott, AG, Blaskovich, MAT and Cooper, MA. Contribution of physicochemical parameters to the antimicrobial activity / toxicity index of β-hairpin peptides. 34th European peptide conference, Leipzig, Germany, September 2016. Edwards, IA, Elliott, AG, Blaskovich, MAT and Cooper, MA. Contribution of physicochemical parameters to the antimicrobial activity / toxicity index of β-hairpin peptides. Queensland Annual Chemistry Symposium, Brisbane, Australia, November 2016. Edwards, IA, Elliott, AG, Blaskovich, MAT and Cooper, MA. Contribution of physicochemical parameters to the antimicrobial activity / toxicity index of β-hairpin peptides. Solution for drug resistant infections, Brisbane, Australia, April 2017. Edwards, IA, Elliott, AG, Blaskovich, MAT, Mobli, M, Solution NMR characterisation of β-hairpin antimicrobial peptides in lipid bilayer nanodiscs, 12th Australian peptides conferences, Noosa, Australia, October 2017 IV Edwards, IA, Elliott, AG, Blaskovich, MAT, Mobli, M, Solution NMR characterisation of β-hairpin antimicrobial peptides in lipid bilayer nanodiscs, ANZMAG (Australian New Zealand Magnetic Resonance) conference, Kingscliff, Australia, December 2017 Contributions by others to the thesis Zhenling Cui designed the plasmid vector mentioned in chapter 5, page 5-110. Alan Zhang performed the expression and purification of cNW9 mentioned in chapter 5, page 5-113. Statement of parts of the thesis submitted to qualify for the award of another degree No works submitted towards another degree have been included in this thesis. Research Involving Human or Animal Subjects The work in this thesis was performed under the ethics approval number 2014000031 granted by NHMRC/ARC agent for the duration period: 17 March 2015 to 31 December 2019, to perform hemolytic assay of red blood cells for compounds with antimicrobial activity. V Acknowledgements Many people have contributed to make my journey through my PhD as smooth as possible
Load more

Recommended publications
  • Simulations of Я-Hairpin Folding Confined to Spherical Pores Using
    Simulations of ␤-hairpin folding confined to spherical pores using distributed computing D. K. Klimov*†, D. Newfield‡, and D. Thirumalai*† *Institute for Physical Science and Technology, University of Maryland, College Park, MD 20742; and ‡Parabon Computation, 3930 Walnut Street, Suite 100, Fairfax, VA 22030-4738 Communicated by George H. Lorimer, University of Maryland, College Park, MD, April 12, 2002 (received for review December 18, 2001) 3 ϱ We report the thermodynamics and kinetics of an off-lattice Go radius of gyration of a chain Rg at D (the size of a chain in ␤ Ӎ ␯ model -hairpin from Ig-binding protein confined to an inert bulk solution) to N according to Rg aN . If the chain is ideal, ␯ ϭ ⌬ ϭ ͞ 2 spherical pore. Confinement enhances the stability of the hairpin then 0.5 and FU RTN(a D) . Because of the reduction due to the decrease in the entropy of the unfolded state. Compared in the translational entropy, confinement also increases the free ⌬ Ͼ ⌬ ͞⌬ ϽϽ with their values in the bulk, the rates of hairpin formation increase energy of the native state, i.e., FN 0. If FN FU 1, then in the spherical pore. Surprisingly, the dependence of the rates on localization of a protein in a confined space stabilizes the native the pore radius, Rs, is nonmonotonic. The rates reach a maximum state compared with the bulk. It also follows that there is a range ͞ b Ӎ b at Rs Rg,N 1.5, where Rg,N is the radius of gyration of the folded of D values over which stability is maximized.
    [Show full text]
  • Associate Professor Yiannis N. Kaznessis
    Yiannis N. Kaznessis Associate Professor Department of Chemical Engineering and Materials Science, and Digital Technology Center, University of Minnesota 421 Washington Ave. S.E., Minneapolis, MN 55455-0132 Tel: (612) 624-4197, Fax: (612) 626-7246, E-mail: [email protected] URL: http://www.cems.umn.edu/research/kaznessis ______________________________________________________________________ Professor Kaznessis’ research interests focus on computer modeling of biological matter, synthetic biology and on statistical mechanical modeling of biomolecular recognition phenomena. Professor Kaznessis teaches undergraduate “Chemical Engineering Thermodynamics”, undergraduate “Process Dynamics and Control” and the graduate course “Statistical Thermodynamics and Kinetics”. Professor Kaznessis is also the Director of the University of Minnesota Summer Bioinformatics Institute. Education Diploma, Chemical Engineering, Aristotle University of Thessaloniki, Greece, 1994. Ph.D., Chemical Engineering, University of Notre Dame, 2000. Postdoctoral Fellowship, University of Michigan and Pfizer Global Research and Development, 08/99-08/01 Appointments ASSOCIATE PROFESSOR, 08/01/07 - present Department of Chemical Engineering and Materials Science, University of Minnesota Digital Technology Center, University of Minnesota DIRECTOR OF GRADUATE STUDIES IN CHEMICAL ENGINEERING, 01/2010 – present Department of Chemical Engineering and Materials Science, University of Minnesota DIRECTOR, 01/01/03-present University of Minnesota Summer Bioinformatics Institute ASSISTANT PROFESSOR, 08/23/01-07/31/07 Department of Chemical Engineering and Materials Science, University of Minnesota Digital Technology Center, University of Minnesota POSTDOCTORAL FELLOW, 08/99-08/01 Biomolecular Structure and Drug Design, Pfizer Global Research and Development. Department of Chemical Engineering, University of Michigan. RESEARCH ASSISTANT, 09/94-08/99 Department of Chemical Engineering, University of Notre Dame, Ph.D. (2000). PROJECT MANAGER ASSISTANT, 12/93-08/94 Euroconsultants S.A., Thessaloniki, Greece.
    [Show full text]
  • The Haemophilus Ducreyi Sap Transporter Contributes
    THE HAEMOPHILUS DUCREYI SAP TRANSPORTER CONTRIBUTES TO ANTIMICROBIAL PEPTIDE RESISTANCE KristyLee BeaversMount SubmittedtothefacultyoftheUniversityGraduateSchool inpartialfulfillmentoftherequirements forthedegreeof DoctorofPhilosophy intheDepartmentofMicrobiologyandImmunology, IndianaUniversity August2009 AcceptedbytheFacultyofIndianaUniversity,inpartial fulfillmentoftherequirementsforthedegreeof DoctorofPhilosophy. ________________________________ MargaretE.Bauer,PhD(Chair) ________________________________ StanleyM.Spinola,MD ________________________________ DoctoralCommittee XiaofengF.Yang,PhD ________________________________ May26th,2009MaryC.Dinauer,MD/PhD ________________________________ MaureenA.Harrington,PhD ii ACKNOWLEDGEMENTS I wouldlike tothankmy friends andmyfamilyfor supportingme throughthis endeavor. It would not have been possible for me to have made it as far as I have without their unwaveringsupportandencouragement. Inparticular,I wouldlike tothankmyparents for providingme witha strongfoundation upon which to build and for their utter confidence that I would succeed, even in the darkestoftimes. I wouldlike tothankJosie HoulihanandJeff Altenburgfor their friendship throughout graduateschool.Iwillrememberthemalways. Most of all I wouldlike tothankmyhusbandfor his love andsupport. He has beenthe rockuponwhichI have dependedandI would not have beenable toachieve mygoals withouthim bymyside.MyPhD belongstohimasmuchas itdoes tome. Finally, I would like to thank my son for continuously reminding me what is most important inlife.
    [Show full text]
  • Jonathan Butcher, Polyphor, Switzerland
    1 BIO 2016 Global Workshop for Novel Anti-Infectives by Jonathan J. Butcher PhD, Polyphor Ltd, Hegenheimermattweg 125, CH-4123, Allschwil, Switzerland Discovery and Development of Novel Macrocycle Antibiotics BIO 2016 Global Workshop for Novel Anti-Infectives – June 6, 2016 2 Murepavadin (POL7080) A once in a generation discovery POL7080, antibiotic against Pseudomonas with a new mode of action POL0067 POL6137 POL7001 POL7080 CCS Protegrin I (1ZY6) Pseudomonas specific! PK/ADMET optimization Srinivas, S., et al. (2010) Science, 327: 1010 – 1012 Very potent and narrow MIC distribution Efficacy of POL7080 in a murine pneumonia (400 recent Pseudomonas strains) model against Pseudomonas aeruginosa (clinical isolate PAX11045, MIC = 0.125 mg/mL) EUCAST Antimicrobial MIC MIC Range 7 50 90 %S / %R Murepavadin 0.12 0.25 0.06 - 1 - / - 6 300 Meropenem 0.5 16 <0.03 - >64 73 / 13 MIC50 Ciprofloxacin 0.12 16 <0.06 - >32 73 / 22 Colistin 1 1 0.25 - 2 100 / - 5 200 CFU/lung 10 4 Log 3 MIC90 100 Number of isolates Numberof 2 Number of isolates of Number MIC99 0 Vehicle 0.06 0.125 0.25 0.5 11 0.5 0.06 0.25 0.125MIC (μg/mL) MIC (µg/mL) MIC (g/ml) Start of treatment POL7080POL7080 5.5 mg/kgPOL7080 11 mg/kgPOL7080 15 mg/kg 22 mg/kg POL7080 2.75 mg/kg Very potent anti-Pseudomonas activity, rapidly bactericidal at 2-4 times the MIC, with a narrow WT distribution. Excellent in vivo efficacy and safety in broad range of systemic infection models, allowed for FIM studies BIO 2016 Global Workshop for Novel Anti-Infectives – June 6, 2016 3 Murepavadin (POL7080) New class of anti-Pseudomonal antibiotics with novel mode of action PK snapshot and summary of clinical studies ongoing or completed AUC and C increase linearly with dose, t is approx.
    [Show full text]
  • Multidimensional Signatures in Antimicrobial Peptides
    Multidimensional signatures in antimicrobial peptides Nannette Y. Yount*† and Michael R. Yeaman*†‡§ *Division of Infectious Diseases, Harbor–UCLA Medical Center, and †St. John’s Cardiovascular Research Center, Research and Education Institute at Harbor–UCLA, Torrance, CA 90502; and ‡David Geffen School of Medicine, University of California, Los Angeles, CA 90024 Communicated by H. Ronald Kaback, University of California, Los Angeles, CA, March 5, 2004 (received for review January 7, 2004) Conventional analyses distinguish between antimicrobial peptides by (iii) published antimicrobial activity, and (iv) up to 75 aa in length. differences in amino acid sequence. Yet structural paradigms common The initial dataset contained over 500 known antimicrobial pep- to broader classes of these molecules have not been established. The tides (see supporting information, which is published on the PNAS current analyses examined the potential conservation of structural web site). From this initial cohort, representatives of specific classes themes in antimicrobial peptides from evolutionarily diverse organ- [e.g., ␣-defensins, ␤-defensins, insect defensins, plant defensins, isms. Using proteomics, an antimicrobial peptide signature was dis- cysteine-stabilized (CS)-␣␤ peptides] were identified on the basis of covered to integrate stereospecific sequence patterns and a hallmark their being well characterized in the literature, having a known 3D three-dimensional motif. This striking multidimensional signature is structure, and being prototypic of their
    [Show full text]
  • Binding of Protegrin-1 to Pseudomonas Aeruginosa and Burkholderia Cepacia Mark T Albrecht1, Wei Wang2, Olga Shamova2, Robert I Lehrer2,3 and Neal L Schiller1
    Available online http://respiratory-research/content/3/1/18 Research3/1/18 RespirVol 3 No Res 1 article Respiratory Research Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia Mark T Albrecht1, Wei Wang2, Olga Shamova2, Robert I Lehrer2,3 and Neal L Schiller1 1Division of Biomedical Sciences, University of California, Riverside, California 92521, USA. 2Department of Medicine, University of California, Los Angeles, Los Angeles, California 90095, USA. 3Molecular Biology Institute, University of California, Los Angeles, Los Angeles, California 90095, USA. Correspondence: Neal L Schiller - [email protected] Received: 1 October 2001 Respir Res 2002, 3:18 Revisions requested: 19 November 2001 Revisions received: 29 January 2002 Accepted: 31 January 2002 © 2002 Albrecht et al, licencee BioMed Central Ltd Published: 14 March 2002 (Print ISSN 1465-9921; Online ISSN 1465-993X) Abstract Background: Pseudomonas aeruginosa and Burkholderia cepacia infections of cystic fibrosis patients' lungs are often resistant to conventional antibiotic therapy. Protegrins are antimicrobial peptides with potent activity against many bacteria, including P. aeruginosa. The present study evaluates the correlation between protegrin-1 (PG-1) sensitivity/resistance and protegrin binding in P. aeruginosa and B. cepacia. Methods: The PG-1 sensitivity/resistance and PG-1 binding properties of P. aeruginosa and B. cepacia were assessed using radial diffusion assays, radioiodinated PG-1, and surface plasmon resonance (BiaCore). Results: The six P. aeruginosa strains examined were very sensitive to PG-1, exhibiting minimal active concentrations from 0.0625–0.5 µg/ml in radial diffusion assays. In contrast, all five B. cepacia strains examined were greater than 10-fold to 100-fold more resistant, with minimal active concentrations ranging from 6–10 µg/ml.
    [Show full text]
  • Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy
    toxins Article Inclusion of a Furin Cleavage Site Enhances Antitumor Efficacy against Colorectal Cancer Cells of Ribotoxin α-Sarcin- or RNase T1-Based Immunotoxins Javier Ruiz-de-la-Herrán 1, Jaime Tomé-Amat 1,2 , Rodrigo Lázaro-Gorines 1, José G. Gavilanes 1 and Javier Lacadena 1,* 1 Departamento de Bioquímica y Biología Molecular, Facultad de Ciencias Químicas, Universidad Complutense de Madrid, Madrid 28040, Spain; [email protected] (J.R.-d.-l.-H.); [email protected] (J.T.-A.); [email protected] (R.L.-G.); [email protected] (J.G.G.) 2 Centre for Plant Biotechnology and Genomics (UPM-INIA), Universidad Politécnica de Madrid, Pozuelo de Alarcón, Madrid 28223, Spain * Correspondence: [email protected]; Tel.: +34-91-394-4266 Received: 3 September 2019; Accepted: 10 October 2019; Published: 12 October 2019 Abstract: Immunotoxins are chimeric molecules that combine the specificity of an antibody to recognize and bind tumor antigens with the potency of the enzymatic activity of a toxin, thus, promoting the death of target cells. Among them, RNases-based immunotoxins have arisen as promising antitumor therapeutic agents. In this work, we describe the production and purification of two new immunoconjugates, based on RNase T1 and the fungal ribotoxin α-sarcin, with optimized properties for tumor treatment due to the inclusion of a furin cleavage site. Circular dichroism spectroscopy, ribonucleolytic activity studies, flow cytometry, fluorescence microscopy, and cell viability assays were carried out for structural and in vitro functional characterization. Our results confirm the enhanced antitumor efficiency showed by these furin-immunotoxin variants as a result of an improved release of their toxic domain to the cytosol, favoring the accessibility of both ribonucleases to their substrates.
    [Show full text]
  • Protein Structure Databases and Classification
    Protein Structure Databases and Classification •SCOP, CATH classification schemes, what they mean. •Motifs: classic turn types. Extended turn types. •TOPS: drawing a protein molecule The SCOP database • Contains information about classification of protein structures and within that classification, their sequences • Go to http://scop.berkeley.edu SCOP classification heirarchy global characteristics (no (1) class evolutionary relation) (2) fold Similar “topology” . Distant (3) superfamily evolutionary cousins? (4) family Clear structural homology (5) protein Clear sequence homology (6) species functionally identical unique sequences protein classes 1. all α (126) number of sub-categories 2. all β (81) 3. α/β (87) 4. α+β (151) 5. multidomain (21) 6. membrane (21) 7. small (10) 8. coiled coil (4) 9. low-resolution (4) possibly not complete, or 10. peptides (61) erroneous 11. designed proteins (17) class: α/β proteins Mainly parallel beta sheets (beta-alpha-beta units) Folds: TIM-barrel (22) swivelling beta/beta/alpha domain (5) spoIIaa-like (2) flavodoxin-like (10) restriction endonuclease-like (2) ribokinase-like (2) Many folds have historical names. chelatase-like (2) “TIM” barrel was first seen in TIM. These classifications are done by eye, mostly. fold: flavodoxin-like 3 layers, α/β/α; parallel beta-sheet of 5 strand, order 21345 Superfamilies: 1.Catalase, C-terminal domain (1) Note the term: “layers” 2.CheY-like (1) 3.Succinyl-CoA synthetase domains (1) These are not domains. 4.Flavoproteins (3) No implication of 5.Cobalamin (vitamin B12)-binding domain (1) structural independence. 6.Ornithine decarboxylase N-terminal "wing" domain (1) Note how beta sheets are 7.Cutinase-like (1) described: number of 8.Esterase/acetylhydrolase (2) strands, order (N->C) 9.Formate/glycerate dehydrogenase catalytic domain-like (3) 10.Type II 3-dehydroquinate dehydratase (1) fold-level similarity common topological features catalase flavodoxin At the fold level, a common core of secondary structure is conserved.
    [Show full text]
  • IX Updating Course of Antimicrobials and Infectious Diseases
    REVISTA ESPAÑOLA DE QQuimioterapiauimioterapia SPANISH JOURNAL OF CHEMOTHERAPY ISSN: 0214-3429 Volume 32 Supplement number 2 September 2019 Pages: 01-79 IX Updating Course of Antimicrobials and Infectious Diseases Coordination: Dr. FJ. Candel González Servicio de Microbiologia Clínica Hospital Clínico San Carlos Madrid. Spain. 18 y 19 de febrero de 2019 Auditorio San Carlos. Pabellón Docente Publicación Oficial Hospital Clínico San Carlos de la Sociedad Española de Quimioterapia REVISTA ESPAÑOLA DE Quimioterapia Revista Española de Quimioterapia tiene un carácter multidisciplinar y está dirigida a todos aquellos profesionales involucrados en la epidemiología, diagnóstico, clínica y tratamiento de las enfermedades infecciosas Fundada en 1988 por la Sociedad Española de Quimioterapia Sociedad Española de Quimioterapia Indexada en Publicidad y Suscripciones Publicación que cumple los requisitos de Science Citation Index Sociedad Española de Quimioterapia soporte válido Expanded (SCI), Dpto. de Microbiología Index Medicus (MEDLINE), Facultad de Medicina ISSN Excerpta Medica/EMBASE, Avda. Complutense, s/n 0214-3429 Índice Médico Español (IME), 28040 Madrid Índice Bibliográfico en Ciencias e-ISSN de la Salud (IBECS) 1988-9518 Atención al cliente Depósito Legal Secretaría técnica Teléfono 91 394 15 12 M-32320-2012 Dpto. de Microbiología Correo electrónico Facultad de Medicina [email protected] Maquetación Avda. Complutense, s/n Kumisai 28040 Madrid [email protected] Consulte nuestra página web Impresión Disponible en Internet: www.seq.es España www.seq.es Esta publicación se imprime en papel no ácido. This publication is printed in acid free paper. LOPD Informamos a los lectores que, según lo previsto © Copyright 2019 en el Reglamento General de Protección Sociedad Española de de Datos (RGPD) 2016/679 del Parlamento Quimioterapia Europeo, sus datos personales forman parte de la base de datos de la Sociedad Española de Reservados todos los derechos.
    [Show full text]
  • Β-Barrel Oligomers As Common Intermediates of Peptides Self
    www.nature.com/scientificreports OPEN β-barrel Oligomers as Common Intermediates of Peptides Self-Assembling into Cross-β Received: 20 April 2018 Accepted: 22 June 2018 Aggregates Published: xx xx xxxx Yunxiang Sun, Xinwei Ge, Yanting Xing, Bo Wang & Feng Ding Oligomers populated during the early amyloid aggregation process are more toxic than mature fbrils, but pinpointing the exact toxic species among highly dynamic and heterogeneous aggregation intermediates remains a major challenge. β-barrel oligomers, structurally-determined recently for a slow-aggregating peptide derived from αB crystallin, are attractive candidates for exerting amyloid toxicity due to their well-defned structures as therapeutic targets and compatibility to the “amyloid- pore” hypothesis of toxicity. To assess whether β-barrel oligomers are common intermediates to amyloid peptides - a necessary step toward associating β-barrel oligomers with general amyloid cytotoxicity, we computationally studied the oligomerization and fbrillization dynamics of seven well- studied fragments of amyloidogenic proteins with diferent experimentally-determined aggregation morphologies and cytotoxicity. In our molecular dynamics simulations, β-barrel oligomers were only observed in fve peptides self-assembling into the characteristic cross-β aggregates, but not the other two that formed polymorphic β-rich aggregates as reported experimentally. Interestingly, the latter two peptides were previously found nontoxic. Hence, the observed correlation between β-barrel oligomers formation and cytotoxicity supports the hypothesis of β-barrel oligomers as the common toxic intermediates of amyloid aggregation. Aggregation of proteins and peptides into amyloid fbrils is associated with more than 25 degenerative diseases, including Alzheimer’s disease (AD)1,2, Parkinson’s disease (PD)3,4, prion conditions5 and type-2 diabetes (T2D)6,7.
    [Show full text]
  • Predicting Protein Secondary and Supersecondary Structure
    29 Predicting Protein Secondary and Supersecondary Structure 29.1 Introduction............................................ 29-1 Background • Difficulty of general protein structure prediction • A bottom-up approach 29.2 Secondary structure ................................... 29-5 Early approaches • Incorporating local dependencies • Exploiting evolutionary information • Recent developments and conclusions 29.3 Tight turns ............................................. 29-13 29.4 Beta hairpins........................................... 29-15 29.5 Coiled coils ............................................. 29-16 Early approaches • Incorporating local dependencies • Predicting oligomerization • Structure-based predictions • Predicting coiled-coil protein interactions Mona Singh • Promising future directions Princeton University 29.6 Conclusions ............................................ 29-23 29.1 Introduction Proteins play a key role in almost all biological processes. They take part in, for example, maintaining the structural integrity of the cell, transport and storage of small molecules, catalysis, regulation, signaling and the immune system. Linear protein molecules fold up into specific three-dimensional structures, and their functional properties depend intricately upon their structures. As a result, there has been much effort, both experimental and computational, in determining protein structures. Protein structures are determined experimentally using either x-ray crystallography or nuclear magnetic resonance (NMR) spectroscopy. While
    [Show full text]
  • Beta Structure Motifs of Islet Amyloid Polypeptides Identified Through Surface-Mediated Assemblies
    Beta structure motifs of islet amyloid polypeptides identified through surface-mediated assemblies Xiao-Bo Mao (毛晓波)a,1, Chen-Xuan Wang (王晨轩)a,b,1, Xing-Kui Wu (吴兴奎)a, Xiao-Jing Ma (马晓晶)a,c, Lei Liu (刘磊)a,LanZhang(张岚)a,LinNiu(牛琳)a, Yuan-Yuan Guo (郭元元)a,Deng-HuaLi(李灯华)a, Yan-Lian Yang (杨延莲)a,2, and Chen Wang (王琛)a,2 aNational Center for Nanoscience and Technology, Beijing 100190, China; bDepartment of Chemistry, Tsinghua University, Beijing 100084, China; and cState Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Science, Changchun 130022, China Edited by* David Eisenberg, University of California, Los Angeles, CA, and approved September 29, 2011 (received for review February 22, 2011) We report here the identification of the key sites for the beta struc- been made in the aggregation behaviors of the mutant analogs ture motifs of the islet amyloid polypeptide (IAPP) analogs by using of IAPP (2, 7, 12, 15, 21–24), while more evidence is still needed scanning tunneling microscopy (STM). Duplex folding structures in to gain insight into the relationship between primary sequences of human IAPP8–37 (hIAPP8–37) assembly were observed featuring the IAPP analogs and the conformational variants. a hairpin structure. The multiplicity in rIAPP assembly structures It is generally acknowledged that the noncrystalline nature of indicates the polydispersity of the rat IAPP8–37 (rIAPP8–37) beta-like the fibril structures formed by amyloidal peptides makes it experi- motifs. The bimodal length distribution of beta structure motifs mentally challenging for structural analyses at molecular level.
    [Show full text]